title: Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment.
abstract: Two common classes of deletions are described in the literature in individuals with Prader-Willi/Angelman syndrome (PWS/AS): one between breakpoint 1 (BP1) to BP3 and the other between BP2 to BP3 of the PWS/AS critical region on chromosome 15q11-->q13. We present here a novel observation of an approximately 253-kb deletion between BP1 and BP2 on 15q11.2, in a 3(1/2)-year-old boy, who was referred to us with a clinical suspicion of having Angelman syndrome and presenting with mental retardation, neurological disorder, developmental delay and speech impairment. Karyotype and FISH results were found to be normal. The microdeletion between BP1 and BP2 includes four genes - NIPA1, NIPA2, CYFIP1 and TUBGCP5 which was detected by a high-resolution oligonucleotide array-CGH that was further validated by a Multiplex Ligation-dependent Probe Amplification (MLPA) assay. The same deletion was observed in the father who presented with similar but relatively milder clinical features as compared to the affected son. Methylation studies by methylation-specific MLPA (MS-MLPA) of the SNRPN imprinting center (IC) showed a normal imprinting pattern, both in the patient and the father. To our knowledge a microdeletion limited only to the BP1-BP2 region has not yet been reported. The familial genetic alteration together with the striking clinical presentation in this study are interesting, but from our single case study it is difficult to suggest if the deletion is causative of some of the abnormal features or if it is a normal variant. The study however further strengthens the fact that genome-wide analysis by array CGH in individuals with developmental delay and mental retardation is very useful in detecting such hidden interstitial chromosomal rearrangements.
authors.affiliation: Genetics Department, Al Wasl Hospital, DOHMS, Dubai, UAE. skmurthy@dohms.gov.ae
authors.forename: S K
authors.initials: SK
authors.lastname: Murthy
authors.forename: A O H
authors.initials: AO
authors.lastname: Nygren
authors.forename: H M
authors.initials: HM
authors.lastname: El Shakankiry
authors.forename: J P
authors.initials: JP
authors.lastname: Schouten
authors.forename: A I
authors.initials: AI
authors.lastname: Al Khayat
authors.forename: A
authors.initials: A
authors.lastname: Ridha
authors.forename: M T
authors.initials: MT
authors.lastname: Al Ali
mesh_terms: D017204:Angelman Syndrome / Q000235:genetics*; D002675:Child, Preschool; D002874:Chromosome Mapping; D019175:DNA Methylation; D005260:Female; D017353:Gene Deletion; D018392:Genomic Imprinting; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008297:Male; D009422:Nervous System Diseases / Q000235:genetics*; D009693:Nucleic Acid Hybridization; D009841:Oligonucleotides / Q000737:chemistry; D010375:Pedigree; D011218:Prader-Willi Syndrome / Q000235:genetics*; D013064:Speech Disorders / Q000235:genetics*
chemical_list: D009841:Oligonucleotides